Immunovant Sciences Gmbh

This study tests an investigational drug called IMVT-1402 (Imeroprubart) in 162 adults with CIDP, a nerve disorder that causes weakness and numbness. The goal is to see if the drug can prevent relapses and improve daily function compared to a placebo. Participants must already be…

This study tests an investigational drug called IMVT-1402 in people with mild to severe generalized myasthenia gravis, a condition that causes muscle weakness. About 231 adults will receive either the drug or a placebo to see if it improves daily activities and muscle strength. T…

This study tests a new drug called IMVT-1402 for adults with Graves' disease whose thyroid levels are still high despite current treatment. About 240 participants will receive either the drug or a placebo to see if it can bring thyroid hormones back to normal and allow patients t…

This study tests a new medication called IMVT-1402 for people with moderate to severe Sjögren's disease, an autoimmune condition causing dryness and other symptoms. About 180 adults will receive either the drug or a placebo to see if it reduces disease activity over 24 weeks. The…

This study tests a new medicine called IMVT-1402 for adults with Graves' disease whose thyroid is still overactive despite current treatments. About 210 participants will receive either the drug or a placebo to see if it can bring thyroid levels back to normal and allow them to s…